Angle reports wider loss, awaits FDA decision on cancer test equipment
Angle reports wider loss, awaits FDA decision on cancer test equipment
Read moreAngle reports wider loss, awaits FDA decision on cancer test equipment
Read moreIN BRIEF: Angle enrolls 200 patients for ovarian cancer test study
Read more(Sharecast News) - Liquid biopsy company Angle announced on Monday that its 200-patient ovarian cancer clinical verification study had completed patient enrolment.
Read moreUK earnings, trading statements calendar - next 7 days
Read more(Sharecast News) - Liquid biopsy company Angle has secured its first large-scale pharma services contract, it announced on Friday.
Read moreTRADING UPDATES: AFC raises GBP36 million; Angle wins service contract
Read moreIN BRIEF: Angle launches clinical services laboratories in UK and US
Read more(Sharecast News) - Liquid biopsy company Angle has completed the fitout and staffing of its clinical services laboratories in Guildford and Pennsylvania, it announced on Tuesday.
Read moreTRADING UPDATES: Futura signs development deal; UKOG gets day in court
Read moreAIM WINNERS & LOSERS: Futura Medical rises on financing transaction
Read moreAngle Shares Jump On Recent Parsortix System Research Results
Read moreIN BRIEF: Angle Says Athens University Study Shows Value Of Parsortix
Read moreTRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash
Read moreAngle Reports Parsortix System Can Isolate Circulating Tumour Cells
Read moreLONDON AIM WINNERS & LOSERS: Sabien Sinks On Ptarmigan Deal Withdrawal
Read more